Literature DB >> 22290441

A novel role for copper in Ras/mitogen-activated protein kinase signaling.

Michelle L Turski1, Donita C Brady, Hyung J Kim, Byung-Eun Kim, Yasuhiro Nose, Christopher M Counter, Dennis R Winge, Dennis J Thiele.   

Abstract

Copper (Cu) is essential for development and proliferation, yet the cellular requirements for Cu in these processes are not well defined. We report that Cu plays an unanticipated role in the mitogen-activated protein (MAP) kinase pathway. Ablation of the Ctr1 high-affinity Cu transporter in flies and mouse cells, mutation of Ctr1, and Cu chelators all reduce the ability of the MAP kinase kinase Mek1 to phosphorylate the MAP kinase Erk. Moreover, mice bearing a cardiac-tissue-specific knockout of Ctr1 are deficient in Erk phosphorylation in cardiac tissue. in vitro investigations reveal that recombinant Mek1 binds two Cu atoms with high affinity and that Cu enhances Mek1 phosphorylation of Erk in a dose-dependent fashion. Coimmunoprecipitation experiments suggest that Cu is important for promoting the Mek1-Erk physical interaction that precedes the phosphorylation of Erk by Mek1. These results demonstrate a role for Ctr1 and Cu in activating a pathway well known to play a key role in normal physiology and in cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22290441      PMCID: PMC3302449          DOI: 10.1128/MCB.05722-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  Beyond the MEK-pocket: can current MEK kinase inhibitors be utilized to synthesize novel type III NCKIs? Does the MEK-pocket exist in kinases other than MEK?

Authors:  Haile Tecle; Jianxing Shao; Yanhong Li; Michael Kothe; Steven Kazmirski; Julie Penzotti; Yuan-Hua Ding; Jeffrey Ohren; Deb Moshinsky; Rocco Coli; Nidhi Jhawar; Emilia Bora; Suzanne Jacques-O'Hagan; Joe Wu
Journal:  Bioorg Med Chem Lett       Date:  2008-10-31       Impact factor: 2.823

Review 2.  New roles for copper metabolism in cell proliferation, signaling, and disease.

Authors:  Michelle L Turski; Dennis J Thiele
Journal:  J Biol Chem       Date:  2008-08-29       Impact factor: 5.157

Review 3.  How do bacterial cells ensure that metalloproteins get the correct metal?

Authors:  Kevin J Waldron; Nigel J Robinson
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

Review 4.  Ras oncogenes: split personalities.

Authors:  Antoine E Karnoub; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07       Impact factor: 94.444

5.  Isolation of intrinsically active (MEK-independent) variants of the ERK family of mitogen-activated protein (MAP) kinases.

Authors:  Vered Levin-Salomon; Konstantin Kogan; Natalie G Ahn; Oded Livnah; David Engelberg
Journal:  J Biol Chem       Date:  2008-10-01       Impact factor: 5.157

6.  A Mek1-Mek2 heterodimer determines the strength and duration of the Erk signal.

Authors:  Federica Catalanotti; Gloria Reyes; Veronika Jesenberger; Gergana Galabova-Kovacs; Ricardo de Matos Simoes; Oliviero Carugo; Manuela Baccarini
Journal:  Nat Struct Mol Biol       Date:  2009-02-15       Impact factor: 15.369

Review 7.  The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders.

Authors:  Yoko Aoki; Tetsuya Niihori; Yoko Narumi; Shigeo Kure; Yoichi Matsubara
Journal:  Hum Mutat       Date:  2008-08       Impact factor: 4.878

8.  Copper chelator ATN-224 inhibits endothelial function by multiple mechanisms.

Authors:  Sarah A Lowndes; Helen V Sheldon; Shijie Cai; Jennifer M Taylor; Adrian L Harris
Journal:  Microvasc Res       Date:  2009-01-27       Impact factor: 3.514

Review 9.  Elevated copper and oxidative stress in cancer cells as a target for cancer treatment.

Authors:  Anshul Gupte; Russell J Mumper
Journal:  Cancer Treat Rev       Date:  2008-09-06       Impact factor: 12.111

Review 10.  Copper chelation in cancer therapy using tetrathiomolybdate: an evolving paradigm.

Authors:  Gazala Khan; Sofia Merajver
Journal:  Expert Opin Investig Drugs       Date:  2009-04       Impact factor: 6.206

View more
  83 in total

1.  The CopRS two-component system is responsible for resistance to copper in the cyanobacterium Synechocystis sp. PCC 6803.

Authors:  Joaquín Giner-Lamia; Luis López-Maury; José C Reyes; Francisco J Florencio
Journal:  Plant Physiol       Date:  2012-06-19       Impact factor: 8.340

2.  Searching for harmony in transition-metal signaling.

Authors:  Christopher J Chang
Journal:  Nat Chem Biol       Date:  2015-10       Impact factor: 15.040

3.  Communication between the N and C termini is required for copper-stimulated Ser/Thr phosphorylation of Cu(I)-ATPase (ATP7B).

Authors:  Lelita T Braiterman; Arnab Gupta; Raghothama Chaerkady; Robert N Cole; Ann L Hubbard
Journal:  J Biol Chem       Date:  2015-02-09       Impact factor: 5.157

Review 4.  Copper signaling in the brain and beyond.

Authors:  Cheri M Ackerman; Christopher J Chang
Journal:  J Biol Chem       Date:  2017-10-30       Impact factor: 5.157

5.  Integrin αV control of Cu homeostasis and cisplatin sensitivity.

Authors:  Xinjian Lin; Xiying Shang; Stephen B Howell
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

6.  Impaired copper transport in schizophrenia results in a copper-deficient brain state: A new side to the dysbindin story.

Authors:  Kirsten E Schoonover; Stacy L Queern; Suzanne E Lapi; Rosalinda C Roberts
Journal:  World J Biol Psychiatry       Date:  2018-12-20       Impact factor: 4.132

Review 7.  Copper suppression as cancer therapy: the rationale for copper chelating agents in BRAFV600 mutated melanoma.

Authors:  Sarah Sammons; Donita Brady; Linda Vahdat; April Ks Salama
Journal:  Melanoma Manag       Date:  2016-09-02

Review 8.  Analytical Methods for Imaging Metals in Biology: From Transition Metal Metabolism to Transition Metal Signaling.

Authors:  Cheri M Ackerman; Sumin Lee; Christopher J Chang
Journal:  Anal Chem       Date:  2016-12-15       Impact factor: 6.986

9.  Copper influx transporter 1 is required for FGF, PDGF and EGF-induced MAPK signaling.

Authors:  Cheng-Yu Tsai; J Cameron Finley; Sameh S Ali; Hemal H Patel; Stephen B Howell
Journal:  Biochem Pharmacol       Date:  2012-07-25       Impact factor: 5.858

10.  Molecular modulation of the copper and cisplatin transport function of CTR1 and its interaction with IRS-4.

Authors:  Cheng-Yu Tsai; Christopher A Larson; Roohangiz Safaei; Stephen B Howell
Journal:  Biochem Pharmacol       Date:  2014-06-23       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.